Monitoring osteoarthritis in horses becomes a long-game issue: full analysis
Monitoring equine osteoarthritis is increasingly being framed as a long-term management task rather than a single diagnostic event. In an April 17, 2026, item from The Horse, Howland Mansfield, DVM, CVA, CVMMP, said horses may show subtle physical and behavioral changes as osteoarthritis progresses, including stiffness, reluctance to go forward, attitude changes, reduced performance, and, over time, more persistent pain and clearer lameness. (thehorse.com)
That message fits with the broader clinical picture in equine practice. The American College of Veterinary Surgeons describes degenerative joint disease in horses as a chronic, slowly progressive condition that can be difficult to recognize early, especially when more than one limb is involved. ACVS notes that pet parents and caretakers may first notice poor or changed performance, stiffness during exercise, or reluctance to lie down or rise, rather than dramatic limping. (acvs.org)
In practice, monitoring disease progression usually starts with repeated history-taking and lameness evaluation. ACVS says the diagnostic workup typically includes watching the horse move through different motions and on different surfaces, along with flexion evaluation and, when indicated, nerve or joint blocks. Once clinicians localize the source of pain, radiographs are often used, though ultrasound, scintigraphy, CT, or MRI may be warranted depending on the case. Older AAEP educational material and equine lameness references similarly emphasize examination in motion as a core part of serial assessment. (acvs.org)
The Horse’s recent osteoarthritis coverage has been consistent on another point: earlier recognition can change management. In related reporting, the publication noted that small shifts in behavior or way of going can signal a progressive inflammatory joint disease, and that once OA is diagnosed, the goal becomes balancing pain relief with preserving joint health and mobility. Another December 2025 Horse item underscored that OA has no cure, but that veterinarians may be able to slow progression and maintain long-term soundness with appropriate diagnosis and management. (thehorse.com)
There are also signs that more standardized monitoring tools are gaining attention. A Frontiers in Veterinary Science paper published in 2026 evaluated a client-specific outcome measure in 17 horses with spontaneous osteoarthritis, using weekly caretaker scoring and veterinary assessments every four weeks, alongside objective gait analysis at defined time points. While that study was tied to a clinical trial setting, it reflects a broader push toward combining clinician-observed lameness, pet parent or caretaker observations, and repeatable scoring systems to track chronic pain over time. (frontiersin.org)
Expert commentary in the available coverage reinforces the need to look beyond overt lameness. Mansfield’s comments to The Horse focused on the subtle physical and behavioral changes that can precede obvious decline, while ACVS notes that OA pain can arise from multiple joint structures, not cartilage alone. That helps explain why some horses present first as “not quite right” in work, attitude, or willingness, rather than with a straightforward single-limb lameness pattern. (thehorse.com)
Why it matters: For equine veterinarians, the practical implication is that monitoring plans should be explicit, repeatable, and individualized. Horses with osteoarthritis often need serial reassessment to determine whether a current regimen, which may include intra-articular therapy, systemic medication, exercise modification, rehabilitation, or shoeing changes, is still meeting clinical goals. Because OA is managed rather than cured, the value of follow-up lies in catching incremental decline early enough to adjust treatment, preserve function, and support welfare. (acvs.org)
What to watch: Expect more discussion around how often horses with OA should be reevaluated, and more uptake of objective monitoring tools, especially as research on biomarkers, gait metrics, and structured chronic pain assessments continues to develop. (frontiersin.org)